Skip to main content
. 2016 Sep 7;15(1):20–41. doi: 10.2450/2016.0101-16

Table I.

Haemoglobin determination in donor selection.

Country Reporting level Method(s) in use
Non-invasive Invasive Sampling pouch
Capillary Venous Venous
Austria National Yes (minority) Yes Grey-zone/doubtful results Yes (1 centre)
Belgium National No Yes (all new donors and failed Hb on previous donation) No Yes (100%)
Bulgaria National No Yes No No
Croatia National Yes (14% in 2014) Yes (86% in 2014) No Yes (apheresis only)
Cyprus National No Yes Yes (apheresis only) No
Czech Republic Institutional No Yes Yes (new WB donors) Yes (regular WB and apheresis donors)
Denmark Regional No No Yes (low Hb on previous donation) Yes
Estonia National No Yes No No
Finland National No Yes Yes (deferred due to low capillary) No
France National No Yes (21%) Yes (low capillary) Yes (100%)
Germany Regional No Yes No No
Greece National Yes (1 centre) Yes No Yes (apheresis donors and some first time female donors)
Italy Local No Yes Yes (low capillary) Yes (100%)
Latvia National No Yes No No
Lithuania Institutional No Yes No No
Luxembourg National No Yes (“trigger events”) Yes (donor candidates and “trigger events”) Yes
Malta National No Yes Yes (low capillary and apheresis) No
Netherlands National No Yes No (only special request) No (for quality control purposes only)
Poland National Yes Yes Yes (once yearly for regular donors) No
Portugal Local No Yes Yes (apheresis donors) Yes (first time WB donors)
Romania Institutional No Yes Yes (apheresis donors or suspicious capillary level) No
Slovakia National No Yes (mobile collections) Yes (donations at BE) Yes (donors tested only from capillary blood)
Slovenia National No Yes 98% Yes 2% (apheresis) No
Spain Regional No (starting 2016) Yes Yes (low capillary) No
Sweden National No (under evaluation) No Yes (candidate donors) Yes (registered donors)
United Kingdom National No Yes Yes (low capillary) No

WB: whole blood; BE: blood establishment; Hb: haemoglobin.